FIELD: chemistry.
SUBSTANCE: invention relates to biotechnology, specifically a method of producing artificial oligonucleotides that are potentially capable of forming non-canonical structures that stable in physiological conditions and conditions close to physiological, said structures being imperfect G-quadruplexes (lmGQ) which include one nucleotide substitution in the G4 plane in the G-quadruplexes (GQ). Said method includes using an algorithm describing nucleotide sequences in form of a defined set of formulae for further synthesis of selected oligonucleotides.
EFFECT: invention enables to use bioinformation analysis to obtain artificial oligonucleotides that are potentially capable of forming a new conformation - imperfect G-quadruplexes.
4 dwg, 2 tbl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
COMBINATORIAL METHOD FOR OBTAINING DNA-APTAMER THROMBIN INHIBITORS AND APTAMER OLIGONUCLEOTIDES (VERSIONS) | 2013 |
|
RU2520094C1 |
THROMBIN INHIBITING DNA-APTAMERS AND METHOD OF STRUCTURE STABILISATION | 2009 |
|
RU2429293C1 |
DOSAGE FORM OF DNA-APTAMER | 2019 |
|
RU2730000C1 |
METHOD FOR CONSTRUCTION OF QUADRUPLEX AND METHOD FOR DETECTION OF NUCLEIC ACID | 2002 |
|
RU2304168C2 |
APTAMERS FOR USE IN INHIBITION AND/OR SUPPRESSION OF TLR9 ACTIVATION | 2017 |
|
RU2789087C2 |
TREATMENT OF PROLIFERATIVE DISEASES WITH APPLICATION OF ANTISENSE OLIGOMER IAP AND CHEMOTHERAPEUTICAL PREPARATION | 2004 |
|
RU2376018C2 |
IMMUNOSTIMULATING OLIGONUCLEOTIDES | 2018 |
|
RU2795701C2 |
DNA APTAMERS TO HUMAN PrimPol PRIMASE AND DNA POLYMERASE | 2020 |
|
RU2770691C2 |
ANTICOAGULANT WITH DIRECT ACTION BASED ON MODULAR BIVALENT DNA OF APTAMER SELECTIVE TO THROMBIN | 2016 |
|
RU2631829C1 |
METHOD FOR DETERMINING SPATIAL STRUCTURE OF BIOMOLECULES | 2020 |
|
RU2751797C1 |
Authors
Dates
2014-03-20—Published
2012-10-04—Filed